DFine, a developer of minimally invasive medical devices for treating vertebral pathologies, has signed two distribution agreements for StabiliT Vertebral Augmentation System. Siad Healthcare and Reflexion Pharma are expected to represent DFine’s StabiliT System in Italy and Morocco, respectively.
DFine said that its StabiliT Vertebral Augmentation System has been commercially available on four continents in 12 countries within North America, Europe, the Middle East, Africa and Latin America.
DFine plans to expand further in Latin America and Canada are scheduled for the fourth quarter of 2010.
RF Kyphoplasty with the StabiliT Vertebral Augmentation System is DFine’s product line providing physicians greater control in the treatment of vertebral compression fractures through site and size specific cavity creation and an ultra high viscosity bone cement over an extended working time using a remotely controlled delivery system to stabilise the fracture, relieve pain and improve patient quality of life.
Kevin Mosher, chief executive officer of DFine, said: “Italy is a significant market for vertebral augmentation and we are pleased to partner with an established distributor, such as Siad Healthcare, to help us continue our European expansion.
“Adding Morocco, along with several additional countries planned for later this year, enables us to continue to expand the company’s global footprint and unique market position as the technology leader in the treatment of vertebral pathologies.”
Based in San Jose, California, DFine is a privately held medical device company to improve patient quality of life through the development of minimally invasive therapeutic devices used to treat pathologies of the vertebrae.